Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population

被引:72
作者
Hiratsuka, M [1 ]
Inoue, T [1 ]
Omori, F [1 ]
Agatsuma, Y [1 ]
Mizugaki, M [1 ]
机构
[1] Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
thiopurine methyltransferase; pharmacogenetics; genetic polymorphism;
D O I
10.1016/S0027-5107(00)00004-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs such as 6-mercaptopurine, B-thioguanine, and azathiopurine. Several mutations in the TPMT gene have been identified which correlate with a low activity phenotype. The molecular basis for the genetic polymorphism of TPMT has been established for European Caucasians, African-Americans, Southwest Asians and Chinese, but it remains to be elucidated in Japanese populations. The frequency of the four allelic variants of the TPMT gene, TPMT*2 (G238C), TPMT*3A (G460A and A719G), TPMT*3B (G460A) and TPMT*3C (A719G) were determined in Japanese samples (n=192) using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. TPMT*3C was found in 0.8% of the samples (three heterozygotes). The TPMT*2, TPMT*3A and TPMT*3B alleles were not detected in any of the samples analyzed. This study provides the first analysis of TPMT mutant allele frequency in a sample of Japanese population and indicates that TPMT*3C is the most common allele in Japanese subjects. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 23 条
[1]   Thiopurine methyltransferase alleles in British and Ghanaian populations [J].
Ameyaw, MM ;
Collie-Duguid, ESR ;
Powrie, RH ;
Ofori-Adjei, D ;
McLeod, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :367-370
[2]   ETHNIC AND GEOGRAPHIC PERSPECTIVES IN SLE [J].
CITERA, G ;
WILSON, WA .
LUPUS, 1993, 2 (06) :351-353
[3]   The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations [J].
Collie-Duguid, ESR ;
Pritchard, SC ;
Powrie, RH ;
Sludden, J ;
Collier, DA ;
Li, T ;
McLeod, HL .
PHARMACOGENETICS, 1999, 9 (01) :37-42
[4]  
de la Moureyre CSV, 1998, HUM MUTAT, V12, P177, DOI 10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO
[5]  
2-E
[6]   PURINE SUBSTRATES FOR HUMAN THIOPURINE METHYLTRANSFERASE [J].
DEININGER, M ;
SZUMLANSKI, CL ;
OTTERNESS, DM ;
VANLOON, J ;
FERBER, W ;
WEINSHILBOUM, RM .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) :2135-2138
[7]  
ESCOUSSE A, 1995, EUR J CLIN PHARMACOL, V48, P309
[8]   Polymorphism of the thiopurine S-methyltransferase gene in African-Americans [J].
Hon, YY ;
Fessing, MY ;
Pui, CH ;
Relling, MV ;
Krynetski, EY ;
Evans, WE .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :371-376
[9]   Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms [J].
Krynetski, EY ;
Tai, HL ;
Yates, CR ;
Fessing, MY ;
Loennechen, T ;
Schuetz, JD ;
Relling, MV ;
Evans, WE .
PHARMACOGENETICS, 1996, 6 (04) :279-290
[10]   A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE [J].
KRYNETSKI, EY ;
SCHUETZ, JD ;
GALPIN, AJ ;
PUI, CH ;
RELLING, MV ;
EVANS, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :949-953